Carter's Retail Momentum Builds: Can Comparable Sales Stay Strong?

Retail net sales rose 9.4% YoY in Q4 2025 with comparable sales up 4.7% (third consecutive positive quarter), driven by e-commerce traffic, higher average unit retail prices and broad-based demand; the baby category recorded its sixth straight quarter of growth. Shares have outperformed, up 7.5% over the past three months versus the industry’s -17.6%, and valuation looks attractive at a forward P/E of 11.69x versus the industry 22.39x; Zacks assigns CRI a Rank #1 (Strong Buy). Management is investing in marketing, product innovation and omnichannel/digital capabilities while targeting higher-income consumers and reducing promotions, though tariffs and cost pressures remain key downside risks to margins.

Analysis

Carter’s omnichannel execution is a structural lever — not a one-off boost — because improving click-to-brick fulfillment and higher AURs compound gross margin expansion by reducing markdown incidence and lowering working-capital drag. Expect inventory turns to improve over 2-4 quarters if fulfillment efficiencies persist; that will show up as expanding gross margin % and faster cash conversion well before top-line catch-up.

A key second-order beneficiary is Carter’s wholesale-less peers and logistics partners: as Carter’s pulls mix toward DTC, department store partners (and brands dependent on wholesale replenishment) face higher inventory write-offs and order volatility, favoring agile, capital-light competitors and 3PLs capturing incremental e-fulfillment volume. Conversely, cotton and tariff volatility remain asymmetric downside risks — a >10% move in input costs or a tariff re-imposition would compress operating leverage quickly because pricing power is still being rebuilt.

The consensus is pricing-optimistic but underestimates demand elasticity at the higher-income cohort Carter’s is targeting; if promotion cadence is cut too quickly, traffic gains could stall within two quarters. That makes a calibrated exposure — capturing margin upside while limiting downside to a macro/cost shock — the most attractive risk-reward profile given current valuation spread vs. peers.

Key Decisions for Investors

• Long CRI equity (size 3-5% of strategy) with 6-12 month horizon: enter on next market dip; target +25% IRR (roughly 20-30% price upside) and hard stop at -12% to limit drawdown if comps roll over.
• Call-spread on CRI to express convexity: buy 9–12 month ATM calls and sell 1.2x strike to fund ~50–60% of premium. This yields ~2x potential return if the stock outperforms in 6–12 months while capping theta bleed; allocate 1–2% of NAV.
• Pairs trade: long CRI / short KTB (equal dollar) for 12 months to play DTC/margin tailwinds vs legacy denim exposure. Expect pair alpha of 10–20% if Carter’s margins expand and Kontoor faces inventory/price pressure; tighten if relative spread narrows >10% in 3 months.
• Hedge tail risk with short-dated puts or buy 3–6 month protective puts on CRI (or buy puts on XLY consumer discretionary ETF) sized to offset >=50% of equity exposure in the event of tariff/input shock — cost acceptable given underappreciated downside risk.